Simplify Processes, Maximize Reimbursements, Empower Care
Oncology and hematology are specialized medical fields focused on the diagnosis, treatment, and management of cancer and blood-related disorders. Oncology deals with tumors and cancer treatments including chemotherapy, immunotherapy, radiation therapy, and surgical interventions. Hematology focuses on disorders affecting the blood, bone marrow, and lymphatic system — including anemia, leukemia, lymphoma, and clotting disorders.
Medical billing and coding in oncology and hematology are among the most complex areas in healthcare revenue cycle management. These specialties involve a wide range of diagnostic tests, infusion therapies, high-cost medication administration, and long-term patient monitoring. Coders must accurately assign CPT codes, ICD-10-CM diagnosis codes, HCPCS Level II drug codes (J-codes), and appropriate modifiers to ensure correct reimbursement.
Oncology billing is particularly complex due to chemotherapy and infusion service rules, high-cost medications and biologics, multiple treatment sessions per month, complex documentation requirements, and strict payer coverage policies.
This guide covers the key CPT codes, ICD-10-CM diagnosis codes, HCPCS drug codes, modifier usage, documentation requirements, and common billing mistakes in oncology and hematology coding for 2026.
Partner with Neolytix to bring precision, efficiency, and expertise to your oncology billing operations.
Scope of Oncology & Hematology Services
Oncology and hematology practices provide a wide range of diagnostic and therapeutic services — delivered primarily in outpatient infusion centers, hospital outpatient departments, and specialized oncology clinics. Common services include:
- Cancer diagnosis and staging
- Chemotherapy administration
- Immunotherapy and targeted therapy
- Blood transfusions
- Bone marrow biopsies and aspirations
- Infusion therapy
- Radiation therapy coordination
- Management of hematologic disorders
- Long-term cancer survivorship care
Common Oncology & Hematology CPT Codes (2026)
Evaluation & Management (E&M) Services
Oncologists frequently bill E&M services for patient consultations, treatment planning, and follow-up care. Under current CMS guidelines, E&M level selection is based on either Medical Decision Making (MDM) or total time spent on the date of service.
CPT Code | Description |
99202–99205 | New patient office visits |
99212–99215 | Established patient office visits |
99221–99223 | Initial hospital care |
99231–99233 | Subsequent hospital care |
Chemotherapy Administration Codes
Chemotherapy administration requires specific CPT codes based on the method and duration of administration. Infusion time must be documented with start and stop times to support the selected code.
| CPT Code | Description |
| 96413 | Chemotherapy infusion — initial hour |
| 96415 | Chemotherapy infusion — each additional hour (add-on) |
| 96411 | Chemotherapy intravenous push |
| 96409 | Non-chemotherapy therapeutic injection |
Infusion Hierarchy Rule: When multiple infusions are administered during the same encounter, coders must follow CMS infusion hierarchy rules. Chemotherapy administration takes priority over therapeutic infusion, which takes priority over hydration. Only one initial service code may be billed per encounter — all additional services of the same type are billed with add-on codes.
Therapeutic Infusion Codes
Some cancer treatments involve infusion therapy using supportive medications, biologics, or hydration rather than chemotherapy agents.
CPT Code | Description |
96365 | Therapeutic infusion — initial hour |
96366 | Therapeutic infusion — each additional hour (add-on) |
96372 | Therapeutic injection |
Bone Marrow Procedures
Bone marrow procedures are essential diagnostic tools in hematology, used to diagnose leukemia, lymphoma, and other blood disorders.
CPT Code | Description |
38221 | Bone marrow biopsy |
38222 | Bone marrow aspiration |
HCPCS Drug Codes (J-Codes)
In oncology billing, medications administered during treatment are reported using HCPCS Level II J-codes in addition to the administration CPT code. Accurate reporting of drug dosage and units is critical — incorrect unit reporting is a leading cause of oncology claim denials and audits.
| HCPCS Code | Description |
| J9190 | Fluorouracil injection |
| J9267 | Paclitaxel injection |
| J9045 | Carboplatin injection |
Drug Unit Billing: J-code units must be reported based on HCPCS guidelines for that specific drug. For example, if a drug is billed per 10 mg unit and the patient receives 50 mg, the claim must report 5 units. Always verify dosage administered against the unit definition in the HCPCS descriptor before submission.
Common ICD-10-CM Codes in Oncology & Hematology (2026)
Cancer diagnosis codes frequently require site specificity and, where applicable, staging information to support medical necessity for high-cost treatments.
ICD-10-CM Code | Description |
C50.919 | Malignant neoplasm of breast, unspecified |
C34.90 | Malignant neoplasm of bronchus and lung, unspecified |
C18.9 | Malignant neoplasm of colon, unspecified |
D64.9 | Anemia, unspecified |
C91.10 | Chronic lymphocytic leukemia, not having achieved remission |
C83.90 | Non-Hodgkin lymphoma, unspecified |
Modifiers Used in Oncology Billing (2026)
Modifier | Description |
25 | Significant, separately identifiable E&M service on the same day as a procedure |
59 | Distinct procedural service — used to bypass NCCI bundling edits |
76 | Repeat procedure performed by the same physician |
26 | Professional component only |
TC | Technical component only |
Oncology Coding & Billing Guidelines
Chemotherapy Infusion Hierarchy
When multiple infusion services are administered during the same encounter, CMS infusion hierarchy rules determine how codes are sequenced and billed. The hierarchy prioritizes chemotherapy administration first, therapeutic infusion second, and hydration third. Only one initial code may be billed per encounter per drug category. All subsequent infusions of the same type are reported with add-on codes. Incorrect sequencing of infusion codes is a consistent reimbursement error in oncology billing.
Drug Unit Reporting
Oncology drug billing requires precise reporting of administered drug units based on the HCPCS descriptor for each J-code. Units must correspond to the actual dosage administered — not the dosage ordered or a rounded figure. Incorrect unit reporting triggers claim denials and may flag accounts for audit. Always verify dosage documentation against the unit definition before submission.
Medical Necessity Documentation
Cancer treatments require strong documentation to justify medical necessity. Every treatment encounter must include the confirmed cancer diagnosis, the treatment protocol being followed, drug dosage and administration method, and the physician’s treatment plan. Payers increasingly require that treatment regimens align with recognized clinical guidelines (e.g., NCCN) to approve high-cost therapies.
Documentation Requirements for Oncology Billing
Oncology documentation must be comprehensive to support the complexity of cancer treatment billing. Clinical records should include:
- Patient diagnosis and cancer staging
- Treatment plan and therapy schedule
- Drug name, dosage, and administration method for each drug administered
- Infusion start and stop times for all timed infusion services
- Patient response to treatment at each encounter
- Complications or adverse reactions documented during or after treatment
Detailed infusion documentation — particularly accurate start and stop times — is critical for correct CPT code selection and unit billing for chemotherapy services.
Compliance and Regulatory Considerations
Oncology billing must comply with CMS billing regulations for infusion therapy and drug administration, NCCI edits for infusion code combinations, Local Coverage Determinations (LCDs) for specific oncology treatments, and Medicare drug administration policies. Given the high cost of oncology treatments, these claims receive heightened scrutiny from both Medicare and commercial payers. Practices should maintain robust internal audit programs focused on infusion coding, drug unit accuracy, and medical necessity documentation.
Common Oncology Billing Denials
Incorrect Drug Unit Reporting
Reporting incorrect dosage units for J-codes is a leading oncology denial trigger. Units must reflect the actual administered dose, mapped to the HCPCS unit definition for that drug. Discrepancies between the administration record and billed units are a primary audit flag.
Missing Infusion Time Documentation
Chemotherapy infusion codes are time-based. Without documented start and stop times, payers cannot verify the duration billed. Missing or incomplete infusion time records result in routine claim denials for timed CPT codes.
Lack of Medical Necessity
Claims may be denied if the treatment protocol is not supported by a valid, site-specific cancer diagnosis or does not align with recognized clinical guidelines. Ensure that diagnosis codes are specific, current, and directly linked to the treatment billed.
Incorrect Infusion Hierarchy Sequencing
Billing infusion codes out of hierarchy order — or billing multiple initial codes in the same encounter — results in reimbursement errors and payer audits. Only one initial service code is permitted per encounter; all subsequent services must follow the hierarchy and use add-on codes.
Preventive Strategies to Reduce Oncology Denials
- Document infusion start and stop times for every timed service at the point of care
- Verify drug dosage administered and confirm correct HCPCS unit calculation before claim submission
- Ensure all diagnosis codes are site-specific and reflect the current treatment indication
- Conduct regular coding audits focused on infusion hierarchy sequencing and J-code unit accuracy
- Monitor payer policy updates for high-cost biologics and emerging oncology therapies
Oncology Billing Workflow
- Patient Registration & Insurance Verification — Collect demographics, confirm coverage, and verify prior authorization for treatments and high-cost drugs
- Cancer Diagnosis & Staging — Document confirmed diagnosis with site specificity and staging
- Treatment Planning & Documentation — Record treatment protocol, drug selection, and dosage plan
- Chemotherapy or Infusion Administration — Administer treatment and document start/stop times and drug dosage
- Medical Coding — Assign CPT, ICD-10-CM, HCPCS J-codes, and modifiers based on documentation
- Claim Submission — Submit claims electronically to payers
- Payment Posting & Reconciliation — Post insurance payments to patient accounts
- Denial Management & Appeals — Review denied claims, identify root causes, correct, and resubmit
Oncology Coding Scenario: Chemotherapy Infusion for Breast Cancer
A patient diagnosed with breast cancer receives intravenous chemotherapy infusion for one hour.
CPT Code:
CPT Code | Description |
96413 | Chemotherapy infusion — initial hour |
HCPCS Code:
HCPCS Code | Description |
J9267 | Paclitaxel injection |
ICD-10-CM Code:
ICD-10-CM Code | Description |
C50.919 | Malignant neoplasm of breast, unspecified |
Documentation must include the drug administered, dosage and units, infusion start and stop times, and the patient’s response to treatment. If a separate E&M visit was performed on the same day, Modifier 25 must be appended to the E&M code.
How Neolytix Supports Oncology & Hematology Practices
Oncology and hematology billing combines some of the highest-cost services in outpatient medicine with some of the most intricate coding requirements — infusion hierarchy rules, J-code unit calculations, multi-drug encounter sequencing, and strict medical necessity documentation standards. Errors in this specialty carry significant financial and compliance consequences.
At Neolytix, we provide:
- Specialty-specific medical billing and coding for oncology and hematology practices
- Medical coding audit services to identify infusion coding gaps and reduce denial rates
- Revenue cycle management to improve collections and accelerate reimbursement for high-cost treatments
- Compliance support including NCCI edit review, J-code unit verification, and infusion hierarchy accuracy
With over 14 years of experience supporting healthcare organizations across the United States, Neolytix brings the expertise your oncology practice needs to stay compliant, reduce denials, and protect revenue.
Schedule a Free Consultation to learn how we can optimize your oncology and hematology billing operations.
Frequently Asked Questions
What CPT codes are used for chemotherapy infusion billing?
CPT 96413 is used for the initial hour of intravenous chemotherapy infusion. CPT 96415 is the add-on code for each additional hour. CPT 96411 is used for intravenous push chemotherapy. Code selection depends on the administration method and duration, both of which must be supported by documented start and stop times.
What are HCPCS J-codes and when are they used in oncology billing?
HCPCS Level II J-codes are used to report the specific drugs administered during oncology treatment. They are billed in addition to the administration CPT code. Each J-code has a defined unit of measurement — for example, per milligram or per 10 mg — and the number of units billed must match the actual administered dosage.
What is the infusion hierarchy rule and why does it matter?
CMS infusion hierarchy rules govern how multiple infusion services are sequenced and billed when more than one drug is administered during the same encounter. Chemotherapy administration takes priority, followed by therapeutic infusion, then hydration. Only one initial service code is permitted per encounter per category — all additional infusions of the same type use add-on codes. Incorrect sequencing leads to reimbursement errors and audit flags.
What documentation is required for chemotherapy infusion billing?
Chemotherapy infusion documentation must include the drug name and dosage administered, infusion start and stop times, the administration method (infusion vs. push), the patient’s response to treatment, and any adverse reactions or complications. Without documented start and stop times, timed infusion codes cannot be supported.
What are the most common oncology billing denials and how can they be prevented?
The most frequent oncology denials involve incorrect J-code unit reporting, missing infusion time documentation, lack of site-specific medical necessity diagnosis coding, and incorrect infusion hierarchy sequencing. Regular coding audits, point-of-care documentation of infusion times, and pre-submission J-code unit verification are the most effective prevention strategies.
